在痴呆症患者个性化预防跌倒 - - 基于登记的研究
Per G Farup1,2, Knut Hestad1, Knut Engedal3,4
1Department of Research and Innovation, Innlandet Hospital Trust, P.O. Box 104, N-2381 Brumunddal, Norway.
Geriatrics (Basel, Switzerland)
|August 27, 2025
概括
对于患有痴呆症的人来说, 个性化防摔非常重要. 跌倒风险及其预测因素,包括步行速度和日常活动,在不同类型的痴呆症之间有很大差异,需要量身定制的干预措施.
科学领域:
- 老年学
- 神经学
- 公共卫生
背景情况:
- 在痴呆症中预防多因素跌倒的效果有限.
- 建议针对有认知障碍的个体制定个性化预防策略.
- 之前的研究发现步行速度,日常生活活动 (ADL) 和抑郁症是主要的跌倒预测因素.
研究的目的:
- 调查与身体,精神和认知功能相关的个人特异性跌倒风险.
- 探索不同类型痴呆症的跌倒风险变化:阿尔茨海默病 (AD),血管痴呆症 (VD),混合AD/VD (MixADVD),前性痴呆症 (FTD) 和具有勒维体的痴呆症 (DLB).
主要方法:
- 使用了"挪威认知症状评估人员登记册" (NorCog) 的数据.
- 分析了痴呆症组之间的差异,并确定了跌倒,步行速度,ADL和康奈尔分数的预测因素.
主要成果:
- 40. 7% 的参与者报告了跌倒,因痴呆症的诊断而有显著差异.
- 跌倒发病率与年龄,并发症,多药性,抑郁症,认知波动以及身体活动减少,步行速度和ADL相关.
- 血管疾病和混合血管疾病的跌倒率很高;与抑郁和波动相关的DLB的跌倒风险很高.
结论:
- 在不同类型的痴呆症中,跌倒的发生率和预测因素有很大差异.
- 有效的个性化干预需要了解个体落风险因素.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Peripheral Artery Disease IV: Nursing Management
43
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
43
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260


